INmune Bio【INMB】株式ニュース

名称	銘柄コード	市場	種別
INmune Bio Inc	INMB	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	0.00	0.00%	9.19	09:00:00

始値	安値	高値	終値	前日終値
				9.19

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/31	05:00	EDGAR2	Form 8-K - Current report
2024/5/30	21:00	GLOBE	INmune Bio Inc. to Join Russell 3000® Index
2024/5/30	05:05	EDGAR2	Form DEF 14A - Other definitive proxy statements
2024/5/24	05:00	EDGAR2	Form 8-K - Current report
2024/5/17	05:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/17	05:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/17	05:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/17	05:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/17	05:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/17	05:00	EDGAR2	Form 8-K - Current report
2024/5/10	05:05	GLOBE	INmune Bio Inc. Announces First Quarter 2024 Results and..
2024/5/07	21:00	GLOBE	INmune Bio Inc. to Report First Quarter 2024 Financial..
2024/4/30	21:00	GLOBE	INmune Bio Inc. Provides Update on Two Patients from the..
2024/4/29	21:00	GLOBE	INmune Bio Inc. Completes First Cohort and Initiates Second..
2024/4/25	22:00	GLOBE	INmune Bio Inc. Announces $9.7 Million Registered Direct..
2024/4/23	21:00	GLOBE	INmune Bio Inc. Announces 24-Month Stability Validation of..
2024/4/22	21:00	GLOBE	INmune Bio Inc. Raises Approximately $4.8 Million in Gross..
2024/4/08	21:00	GLOBE	INmune Bio Inc. Presents Data on INB03’s Role as an Immune..
2024/3/29	05:01	GLOBE	INmune Bio Inc. Announces Year End 2023 Results and Provides..
2024/3/27	05:01	GLOBE	INmune Bio Inc. to Report Fourth Quarter 2023 Financial..
2024/3/13	21:00	GLOBE	INmune Bio CSO and Co-Founder Mark Lowdell, Ph.D. Receives..
2024/3/05	22:00	GLOBE	INmune Bio Reports Significant EEG Improvement in..
2024/2/12	23:00	GLOBE	INmune Bio to Participate in the Oppenheimer 34th Annual..
2024/2/06	23:00	GLOBE	INmune Bio to Participate in Baird’s Biotech Discovery..
2024/1/30	22:02	EDGAR2	Form 8-K - Current report
2024/1/30	22:00	GLOBE	INmune Bio Announces FDA Removal of Clinical Hold for..
2024/1/16	22:30	GLOBE	ELEVAI Labs, Inc. Acquires Worldwide License Agreement for..
2024/1/03	06:00	EDGAR2	Form 8-K - Current report
2024/1/02	22:00	GLOBE	INmune Bio Announces First Patient Dosed in a Phase 1/2..
2023/12/19	06:15	EDGAR2	Form 8-K - Current report
2023/12/19	06:05	EDGAR2	Form 8-A12B/A - Registration of securities [Section 12(b)]:..
2023/12/19	06:01	EDGAR2	Form 8-K - Current report
2023/12/19	06:01	GLOBE	INmune Bio Provides Update Regarding Global Alzheimer’s..
2023/11/30	06:00	EDGAR2	Form 8-K - Current report
2023/11/29	22:00	GLOBE	INmune Bio Inc. Demonstrates that INB03 Enhances the Uptake..
2023/11/28	06:00	EDGAR2	Form 8-K - Current report
2023/11/27	22:00	GLOBE	INmune Bio Receives EMA’s Authorization in France and Spain..
2023/11/16	06:13	EDGAR2	Form 8-K - Current report
2023/11/15	23:00	GLOBE	INmune Bio Inc. Announces Expansion of Phase II Clinical..
2023/11/14	01:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/02	05:13	EDGAR2	Form 8-K - Current report
2023/11/02	05:10	GLOBE	INmune Bio Inc. Announces Third Quarter 2023 Results and..
2023/11/02	05:05	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/01	05:25	EDGAR2	Form 8-K - Current report
2023/10/31	21:00	GLOBE	INmune Bio Inc. Patent Claims Covering INB16 Cell Line and..
2023/10/30	22:07	GLOBE	INmune Bio Inc. Presents Preclinical Data at SITC 2023..
2023/10/17	21:00	GLOBE	INmune Bio Inc. Presents New Biomarker and Feasibility Data..
2023/10/16	22:00	GLOBE	INmune Bio Inc. to Report Third Quarter 2023 Financial..
2023/9/07	22:10	EDGAR2	Form 8-K - Current report
2023/9/07	22:00	GLOBE	INmune Bio Inc. to Present at Baird Global Healthcare..